Vitiligo: A Review
The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Abstract
Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of the population worldwide. The disease is characterized by the selective loss of melanocytes which results in typical nonscaly, chalky-white macules. In recent years, considerable progress has been made in our understanding of the pathogenesis of vitiligo which is now clearly classified as an autoimmune disease. Vitiligo is often dismissed as a cosmetic problem, although its effects can be psychologically devastating, often with a considerable burden on daily life. In 2011, an international consensus classified segmental vitiligo separately from all other forms of vitiligo, and the term vitiligo was defined to designate all forms of nonsegmental vitiligo. This review summarizes the current knowledge on vitiligo and attempts to give an overview of the future in vitiligo treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Data on the incidence of vitiligo are scarce; in Europe, the prevalence rate of diagnosed vitiligo ranges from 0.2% to 0.8%, with geographical and methodological differences. 1,3,4”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [1]
In the citing paper
“Data on the incidence of vitiligo are scarce; in Europe, the prevalence rate of diagnosed vitiligo ranges from 0.2% to 0.8%, with geographical and methodological differences. 1,3,4”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [1]
Citations
Cites
Items 201–270 of 270
Mofty, A. M. E., & Mofty, M. E. (1980) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1980.tb00316.x · Cited by 62
Ezzedine, K., Diallo, A., Léauté-Labrèze, C., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10709.x · Cited by 62
Self-citationLi, R., Qiao, M., Wang, X., Zhao, X., & Sun, Q. (2016) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12277 · Cited by 61
Batcioglu, K., Ozturk, I., Karatas, F., Hazneci, E., & Genc, M. (2008) · Indian Journal of Dermatology · doi:10.4103/0019-5154.39577 · Cited by 60
Clinical and histopathologic characteristics of trichrome vitiligo
Hann, S., Kim, Y. S., Yoo, J. H., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104896 · Cited by 60
Bae, J. M., Hong, B. Y., Lee, J. H., Lee, J. H., & Kim, G. M. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.11.044 · Cited by 60
A review of non-cultured epidermal cellular grafting in vitiligo
van Geel, N., Goh, B. K., Wallaeys, E., et al. (2011) · Journal of Cutaneous and Aesthetic Surgery · doi:10.4103/0974-2077.79181 · Cited by 59
Shah, R., Hunt, J., Webb, T. L., & Thompson, A. R. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12990 · Cited by 59
Treatment of generalized vitiligo with anti-TNF-α Agents.
AlGhamdi, K. M., Khurrum, H., Taı̈eb, A., et al. (2012) · PubMed · Cited by 59
Vitiligo presentation in adults.
Mason, C., & Gawkrodger, D. J. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01779.x · Cited by 58
Kostyuk, V. A., Potapovich, A. I., Cesareo, E., Brescia, S., Guerra, L., Valacchi, G., Pecorelli, A., Deeva, I. B., Raskovic, D., Luca, C. D., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2976 · Cited by 57
Parambath, N., Sharma, V., Parihar, A. S., et al. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14286 · Cited by 56
HSP70iQ435A-Encoding DNA Repigments Vitiligo Lesions in Sinclair Swine
Henning, S. W., Fernandez, M. F., Mahon, J. P., Duff, R., Azarafrooz, F., Guevara-Patiño, J. A., Rademaker, A. W., Salzman, A. L., & Le Poole, I. C. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.06.186 · Cited by 55
The distribution pattern of segmental vitiligo: clues for somatic mosaicism
van Geel, N., Speeckaert, R., Melsens, E., Toelle, S. P., Speeckaert, M. M., Schepper, S. D., Lambert, J., & Brochez, L. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12013 · Cited by 54
Nada, H. R., Sharkawy, D. A. E., Elmasry, M. F., Rashed, L. A., & Mamdouh, S. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-017-1792-6 · Cited by 54
Vitiligo: concise evidence based guidelines on diagnosis and management
Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri-Sole, I., Whitton, M. E., Watts, M. J., Anstey, A. V., Ingham, J., & Young, K. (2010) · Postgraduate Medical Journal · doi:10.1136/pgmj.2009.093278 · Cited by 53
Segmentale Typ-2-Manifestation autosomal dominanter Hautkrankheiten
Happle, R. (2001) · Der Hautarzt · doi:10.1007/s001050051309 · Cited by 52
Rao, J., & FITZPATRICK, R. E. (2004) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2004.30313.x · Cited by 52
Quality-of-Life Issues in Vitiligo
Bhandarkar, S. S., & Kundu, R. V. (2011) · Dermatologic Clinics · doi:10.1016/j.det.2011.11.013 · Cited by 51
Falabella, R., Escobar, C., Carrascal, E., et al. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70071-7 · Cited by 51
Hann, S., Park, Y., & Chun, W. H. (1997) · Clinics in Dermatology · doi:10.1016/s0738-081x(97)00130-2 · Cited by 50
Dermatology Life Quality Index score in vitiligo patients: a pilot study among young Italian males.
Ingordo, V., Cazzaniga, S., Gentile, C., Iannazzone, S. S., Cusano, F., & Naldi, L. (2012) · PubMed · Cited by 50
Eleftheriadou, V., Hamzavi, I. H., Pandya, A. G., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.17013 · Cited by 50
Promoter Variant in the Catalase Gene Is Associated with Vitiligo in Chinese People
Liu, L., Li, C., Gao, J., Li, K., Zhang, R., Wang, G., Li, C., & Gao, T. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.192 · Cited by 49
Khattab, F. M., Abdelbary, E. H., & Fawzi, M. M. (2019) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.13103 · Cited by 49
Etanercept in the Treatment of Vitiligo
Rigopoulos, D., Gregoriou, S., Larios, G., et al. (2007) · Dermatology · doi:10.1159/000102044 · Cited by 47
Activation of the Unfolded Protein Response in Vitiligo: The Missing Link?
Passeron, T., & Ortonne, J. P. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.328 · Cited by 47
Measurement Properties of Outcome Measures for Vitiligo: A Systematic Review
Vrijman, C., Linthorst Homan, M. W., Limpens, J., van der Veen, W., Wolkerstorfer, A., Terwee, C. B., & Spuls, P. I. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.3065 · Cited by 46
Vinay, K., Dogra, S., Parsad, D., et al. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12426 · Cited by 45
Depigmentation Therapy with Q-Switched Ruby Laser After Tanning in Vitiligo Universalis
Kim, Y., Chung, B., & Choi, K. C. (2001) · Dermatologic Surgery · doi:10.1046/j.1524-4725.2001.01101.x · Cited by 44
Serpentine Supravenous Fluorouracil Hyperpigmentation
Hrushesky, W. J. M. (1976) · JAMA · doi:10.1001/jama.1976.03270020012002 · Cited by 43
The Role of Diet and Supplements in Vitiligo Management
Grimes, P. E., & Nashawati, R. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2016.11.012 · Cited by 43
Akyol, M., Çelik, V. K., Özçelik, S., et al. (2002) · PubMed · Cited by 42
Ezzedine, K., Thuaut, A. L., Jouary, T., et al. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12186 · Cited by 41
Self-citationSilverberg, N. B. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32833b6ac3 · Cited by 41
Attili, V. R., & Attili, S. K. (2013) · Indian Journal of Dermatology · doi:10.4103/0019-5154.119949 · Cited by 40
Kottner, J., Jacobi, L., Hahnel, E., Alam, M., Balzer, K., Beeckman, D., Busard, C., Chalmers, J., Deckert, S., Eleftheriadou, V., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16324 · Cited by 40
Hypochromic vitiligo: delineation of a new entity
Ezzedine, K., Mahé, A., van Geel, N., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13423 · Cited by 39
Self-citationA study of hair follicular transplantation as a treatment option for vitiligo
Thakur, P., Sacchidanand, S., Nataraj, H. V., et al. (2015) · Journal of Cutaneous and Aesthetic Surgery · doi:10.4103/0974-2077.172192 · Cited by 39
The classification of segmental vitiligo on the face
Hann, S. K., Chang, J. H., Lee, H., et al. (2000) · Yonsei Medical Journal · doi:10.3349/ymj.2000.41.2.209 · Cited by 38
Noh, S., Kim, M., Park, C. O., Hann, S.-K., & Oh, S. H. (2013) · Annals of Dermatology · doi:10.5021/ad.2013.25.4.454 · Cited by 35
Chang, H., Hsu, Y., & Huang, Y. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.07.108 · Cited by 35
Lin, M., Zhang, B., Shen, N., Dong, X., Zhang, C., Qi, X., Zhu, J., Li, Y.-Z., Man, M., & Tu, C. (2014) · European Journal of Dermatology · doi:10.1684/ejd.2014.2436 · Cited by 34
Mapar, M. A., Mapar, M. A., Safarpour, M., et al. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.11.044 · Cited by 34
Cumulative Life Course Impairment in Vitiligo
Krüger, C., & Schallreuter, K. U. (2013) · Current problems in dermatology · doi:10.1159/000350010 · Cited by 33
Al‐Shobaili, H. A., & Rasheed, Z. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.09.003 · Cited by 33
Diallo, A., Boniface, K., Jouary, T., Sénéschal, J., Morice‐Picard, F., Prey, S., Cario, M., Mazereeuw‐Hautier, J., Taı̈eb, A., & Ezzedine, K. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12065 · Cited by 33
Self-citationBimatoprost 0.03% Solution for the Treatment of Nonfacial Vitiligo.
Grimes, P. E. (2016) · PubMed · Cited by 31
Dang, Y., Li, Q., Shi, F., Yuan, X., & Liu, W. (2015) · Dermatologic Therapy · doi:10.1111/dth.12295 · Cited by 29
Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab
Maruthappu, T., Leandro, M. J., & Morris, S. (2013) · Dermatologic Therapy · doi:10.1111/dth.12002 · Cited by 28
Teulings, H. E., Willemsen, K. J., Glykofridis, I. E., Krebbers, G., Komen, L., Kroon, M. W., Kemp, E. H., Wolkerstorfer, A., van der Veen, J. P. W., Luiten, R. M., et al. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12294 · Cited by 27
Clinical Course of Segmental Vitiligo: A Retrospective Study of Eighty-Seven Patients
Park, J., Jung, M.-Y., Lee, J., et al. (2014) · Annals of Dermatology · doi:10.5021/ad.2014.26.1.61 · Cited by 25
Worsening of Vitiligo and Onset of New Psoriasiform Dermatitis following Treatment with Infliximab
AlGhamdi, K. M., Khurrum, H., & Rikabi, A. (2011) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2011.10068 · Cited by 24
5-Fluorouracil as an adjuvant therapy along with microneedling in vitiligo
Jha, A. K., & Sonthalia, S. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.12.008 · Cited by 24
Wilson, B. B. C. (1979) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1979.tb01924.x · Cited by 22
Tan, E. S. T., & Sarkany, R. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13642 · Cited by 22
Beyond Traditional Treatment: The Importance of Psychosocial Therapy in Vitiligo.
Rzepecki, A. K., McLellan, B. N., & Elbuluk, N. (2018) · PubMed · Cited by 21
Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
Abdou, A. G., Maraee, A. H., Yassien, H., & Sarhan, M. (2018) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2018.09.18 · Cited by 20
Bulut, H., Pehlıvan, M., Alper, S., et al. (2011) · Genetics and Molecular Research · doi:10.4238/2011.october.31.12 · Cited by 18
Intradermal injection of Fluorouracil versus triamcinolone in localized vitiligo treatment
Zohdy, H. A., & Hussein, M. S. (2018) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12820 · Cited by 15
Kottner, J., Jacobi, L., Hahnel, E., Alam, M., Balzer, K., Beeckman, D., Busard, C. I., Chalmers, J. R., Deckert, S., Eleftheriadou, V., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16506 · Cited by 14
Treatment with Modified Heat Shock Protein Repigments Vitiligo Lesions in Sinclair Swine
Frisoli, M. L., & Harris, J. E. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.08.003 · Cited by 9
Vitiligo et phénomène de Koebner suite à des injections de plasma riche en plaquettes
Ejjiyar, M., Sahibi, M., Gueouatri, M. E., et al. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.32.58.16779 · Cited by 7
Combined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo
Kawalek, A. Z., SPENCER, J. M., & Phelps, R. G. (2004) · Dermatologic Surgery · doi:10.1097/00042728-200402000-00002 · Cited by 7
Time for a patient-oriented outcome in vitiligo: the vitiligo noticeability scale
Ezzedine, K., & Pandya, A. G. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14378 · Cited by 6
Self-citationAlGhamdi, K. M., Khurrum, H., & Rikabi, A. (2011) · Cited by 5
The long road to valid outcomes in vitiligo
Wolkerstorfer, A. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17409 · Cited by 5
Clinical application of platelet-rich plasma in vitiligo: a pilot study
Lim, H. K., Shin, M. K., & Lee, M. (2011) · 프로그램북(구 초록집) · Cited by 4
Beauty That Is More Than Skin Deep
Román, J. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.4762 · Cited by 3
Sardana, K., & Verma, G. (2018) · Journal of Cutaneous and Aesthetic Surgery · doi:10.4103/jcas.jcas_68_17 · Cited by 3
Cited by
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
Qi, F., Liu, F., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790125 · Cited by 203
Faraj, S., Kemp, E. H., & Gawkrodger, D. J. (2022) · Clinical and Experimental Immunology · doi:10.1093/cei/uxab002 · Cited by 94
Baicalein inhibits RLS3-induced ferroptosis in melanocytes
Yang, M., Li, X., Li, H., Zhang, X., Liu, X., & Song, Y. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.05.010 · Cited by 53
Eleftheriadou, V., Delattre, C., Chetty-Mhlanga, S., Lee, C., Girardat-Rotar, L., Khan, I., Mathew, A., & Thompson, A. R. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae133 · Cited by 21
Metadata
- Authors
- Bergqvist, C., & Ezzedine, K.
- Affiliations
- Université Paris-Est Créteil (FR)
- Venue
- Dermatology
- Publisher
- S. Karger AG
- Published
- 2020
- Volume
- 236
- Issue
- 6
- Pages
- 571-592
- ISSN
- 1018-8665 (ISSN-L)
- 1421-9832
- OpenAlex
- W3012531490
- Cited by
- 799
- References
- 270
- Citations by year
- 2026: 104 · 2025: 167 · 2024: 160 · 2023: 188 · 2022: 121 · 2021: 44 · 2020: 15
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dermatology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Health Sciences › Medicine › Dermatology › Hair Growth and Disorders
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Keywords
- vitiligo, melanocyte loss, autoimmune disease, vitiligo pathogenesis, segmental vitiligo, non-segmental vitiligo, vitiligo classification, psychological burden, vitiligo treatment
- MeSH terms
- Humans, Quality of Life, Vitiligo, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.